
Leverage the utility of genome sequencing automation
Our liquid handling includes cDNA synthesis, amplification of targets, indexing, nucleic acid clean-up, and initiating the sequencing run with no manual library preparation required.
A fully automated, next-generation sequencing platform that offers complete characterization of bacterial, fungal, and viral pathogens across a wide range of applications. Built to deliver accurate and near real-time results, Clear Dx™ is revolutionizing the way clinical and public health labs approach diagnostics and genomic surveillance.
Our fully automated sequencing platform helps you work quickly and efficiently—offering you the agility to address pathogen outbreaks and more productive time to perform other lab tasks.
Our liquid handling includes cDNA synthesis, amplification of targets, indexing, nucleic acid clean-up, and initiating the sequencing run with no manual library preparation required.
Clear Dx™ reduces hands-on time from several hours to less than 45 minutes where no genomics expertise is required, cuts down the number of human touch points from dozens of manual steps to 1, and decreases the time to results from next-week to next-day.
By enabling fully automated next-generation sequencing of pathogens, Clear Dx™ offers one seamless solution within a single lab shift, helping to facilitate more timely decision-making.
Clear Dx™ allows you to generate the same outcome repeatedly—which reduces workflow errors, increases the consistency of results, boosts your overall productivity, and ultimately improves your organization’s genomic surveillance.
Through pathogen sequencing automation, Clear Dx™ helps you connect insights with unparalleled speed and precision.
Clear Dx helps you generate accurate test results that you can act on with confidence.
With our comprehensive Clear Dx™ workflow, you can manage and interpret your data—and act on it accordingly—without the need for bioinformatics specialists. Featured in the platform are data integration and connectivity solutions that help to streamline genomic surveillance.
The Clear Dx™ software offering for genomic metadata analysis places high priority on protecting the integrity and availability of customer data.
Open API integration as well as sequencing files and quality metrics for each sample are available for download after analysis.
Perform simplified sample registration and result analysis without the need for manual, error-prone interaction.
Clear Dx’s comprehensive and fully automated sequencing platform significantly reduces the level of effort typically required for infectious disease surveillance.
Our fully automated next-generation sequencing workflow consist of only one human touchpoint vs. dozens.
Increase lab tech productivity through automated sequencing, as technologists can perform other tasks after loading samples onto the Clear Dx™ instrument.
Learn how the Clear Dx™ platform performs versus existing methods.
Use Clear Dx™ Microbial ID tNGS to quickly detect multiple bacteria and/or fungi that are difficult to culture from a human specimen.
Use Clear Dx™ Deeplex® Myc-TB to quickly characterize Mycobacterium DNA extracts from isolates or sputum.
Clear Dx™ Microbial Surveillance WGS automates the entire process for whole genome sequencing of bacteria, fungi, and viruses with flexible workflow options, with or without nucleic acid extraction, and supporting a wide range of input concentrations.
Clear Dx WGS SARS-CoV-2 provides fully automated whole genome sequencing of RNA extracts and assembled FASTA files utilizing long-read sequencing technology.
The Clear Dx FlexPro: Wastewater (SARS-CoV-2) provides fully automated whole genome sequencing of RNA extracts of SARS-CoV-2 from wastewater utilizing short-read sequencing technology.
Clear Dx - For more information regarding implementation of the fully-automated NGS platform, the Clear Dx System, at your facility, including purchase and lease arrangements, please contact 650.257.3304.